| Bioactivity | CGP 36742 is a selective GABAB receptor antagonist that can penetrate the blood–brain barrier after peripheral administration, with an IC50 of 32 μM. CGP 36742 is useful in treatment of depression[1]. | ||||||||||||
| Target | IC50: 32 μM (GABAB) | ||||||||||||
| Name | CGP 36742 | ||||||||||||
| CAS | 123690-78-8 | ||||||||||||
| Formula | C7H18NO2P | ||||||||||||
| Molar Mass | 179.20 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Nowak G, et al. Antidepressant-like activity of CGP 36742 and CGP 51176, selective GABAB receptor antagonists, in rodents. Br J Pharmacol. 2006 Nov;149(5):581-90. |
CGP 36742
CAS: 123690-78-8 F: C7H18NO2P W: 179.20
CGP 36742 is a selective GABAB receptor antagonist that can penetrate the blood–brain barrier after peripheral administ
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.